Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 24  •  04:00PM ET
12.66
Dollar change
+0.16
Percentage change
1.28
%
Index- P/E256.28 EPS (ttm)0.05 Insider Own27.46% Shs Outstand160.61M Perf Week5.76%
Market Cap2.03B Forward P/E23.40 EPS next Y0.54 Insider Trans-0.12% Shs Float116.52M Perf Month9.66%
Enterprise Value2.18B PEG22.46 EPS next Q0.11 Inst Own81.83% Short Float13.26% Perf Quarter14.36%
Income7.98M P/S5.01 EPS this Y-4.02% Inst Trans5.49% Short Ratio9.34 Perf Half Y-10.66%
Sales405.75M P/B1.90 EPS next Y25.26% ROA0.52% Short Interest15.45M Perf YTD18.87%
Book/sh6.67 P/C12.53 EPS next 5Y11.41% ROE0.76% 52W High15.69 -19.31% Perf Year12.73%
Cash/sh1.01 P/FCF20.25 EPS past 3/5Y5.33% -5.78% ROIC0.58% 52W Low8.64 46.61% Perf 3Y9.99%
Dividend Est.- EV/EBITDA21.44 Sales past 3/5Y10.42% 13.06% Gross Margin47.46% Volatility3.48% 5.07% Perf 5Y-
Dividend TTM- EV/Sales5.37 EPS Y/Y TTM110.05% Oper. Margin7.20% ATR (14)0.57 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.16 Sales Y/Y TTM11.61% Profit Margin1.97% RSI (14)55.04 Recom2.08
Dividend Gr. 3/5Y- - Current Ratio2.16 EPS Q/Q84.42% SMA200.54% Beta1.45 Target Price14.75
Payout- Debt/Eq0.29 Sales Q/Q12.06% SMA508.33% Rel Volume0.61 Prev Close12.50
Employees1546 LT Debt/Eq0.28 EarningsNov 06 AMC SMA2007.96% Avg Volume1.65M Price12.66
IPODec 11, 2020 Option/ShortYes / Yes EPS/Sales Surpr.-29.65% 0.50% Trades Volume1,006,616 Change1.28%
Date Action Analyst Rating Change Price Target Change
Sep-29-25Initiated Craig Hallum Buy $16
Jul-03-25Resumed Morgan Stanley Equal-Weight $16
May-08-25Upgrade Barclays Equal Weight → Overweight $14
Feb-27-25Initiated TD Cowen Buy $16
Sep-27-24Upgrade UBS Neutral → Buy $16
Apr-10-24Upgrade KeyBanc Capital Markets Sector Weight → Overweight $23
Apr-04-24Initiated JMP Securities Mkt Perform
Feb-26-24Initiated Leerink Partners Market Perform $19
Dec-07-23Initiated UBS Neutral $17
Dec-05-23Initiated KeyBanc Capital Markets Sector Weight
Oct-20-25 08:00AM
Oct-10-25 08:00AM
Oct-02-25 09:13AM
Sep-04-25 08:00AM
Sep-02-25 04:15PM
03:28PM Loading…
Aug-07-25 03:28PM
Aug-06-25 06:00PM
04:15PM
Aug-04-25 02:00AM
Jul-31-25 04:15PM
10:00AM
Jul-30-25 10:00AM
Jul-29-25 08:25AM
Jul-18-25 08:38AM
Jul-15-25 01:56PM
12:10PM Loading…
Jul-11-25 12:10PM
Jul-10-25 12:39AM
Jul-09-25 04:15PM
Jul-08-25 12:05PM
08:00AM
Jun-28-25 09:10AM
Jun-20-25 08:25AM
May-23-25 09:17AM
May-06-25 08:31AM
03:09AM
May-05-25 07:22PM
05:45PM
04:15PM
Apr-29-25 04:15PM
10:01AM
10:00AM Loading…
Apr-28-25 10:00AM
Apr-21-25 08:00AM
Apr-16-25 12:10PM
Apr-15-25 12:40AM
Apr-14-25 08:15AM
08:00AM
Apr-12-25 06:45PM
02:10AM
Apr-11-25 01:15PM
10:04AM
Apr-02-25 12:49PM
Apr-01-25 08:00AM
Mar-06-25 07:58PM
Mar-05-25 04:15PM
Feb-27-25 07:59AM
02:28AM
Feb-26-25 06:45PM
04:15PM
Feb-14-25 01:12PM
Jan-29-25 04:15PM
Jan-24-25 12:48PM
Jan-15-25 07:55AM
Jan-02-25 04:15PM
Dec-06-24 10:02AM
Dec-02-24 04:15PM
Nov-13-24 09:29AM
Nov-07-24 10:38AM
02:27AM
Nov-06-24 07:05PM
04:15PM
Oct-28-24 04:15PM
Oct-16-24 04:15PM
Oct-15-24 08:05AM
Oct-09-24 04:15PM
Oct-02-24 04:15PM
Sep-27-24 07:20PM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Sep-17-24 11:02AM
Aug-28-24 07:03PM
Aug-21-24 04:15PM
Aug-15-24 04:15PM
Aug-12-24 03:57AM
Aug-07-24 12:25PM
Aug-06-24 06:25PM
04:15PM
Jul-09-24 04:45PM
Jul-02-24 04:15PM
Jun-17-24 08:00AM
May-29-24 04:15PM
May-21-24 08:00AM
May-09-24 02:45PM
May-08-24 01:16PM
05:48AM
04:13AM
May-07-24 06:40PM
05:59PM
04:15PM
May-06-24 03:19AM
Apr-16-24 08:00AM
Apr-09-24 04:15PM
Apr-04-24 07:01PM
Mar-02-24 08:41AM
Mar-01-24 07:10AM
Feb-29-24 06:05PM
04:52PM
04:10PM
Feb-01-24 04:30PM
Jan-31-24 11:03PM
Dec-13-23 04:30PM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSep 09 '25Sale10.9251,224559,36673,979Sep 11 04:47 PM
Pedersen Leif EOfficerSep 09 '25Proposed Sale10.9251,224559,304Sep 09 04:16 PM
Anhalt RonaChief Human Resources OfficerMay 30 '25Option Exercise0.007,14607,146Jun 02 04:58 PM
Corcoran DanielSVP and General CounselMay 30 '25Option Exercise0.0022,828020,530Jun 02 04:57 PM
WALSH MATTHEW MDirectorMay 21 '25Option Exercise0.0011,9280197,559May 22 05:07 PM
Reynders John V WDirectorMay 21 '25Option Exercise0.0010,709010,709May 22 05:05 PM
Killefer NancyDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:04 PM
Crane Rosemary ADirectorMay 21 '25Option Exercise0.0011,928029,915May 22 05:03 PM
Collins CynthiaDirectorMay 21 '25Option Exercise0.0011,928036,089May 22 05:01 PM
CASHMAN JAMES E IIIChairmanMay 21 '25Option Exercise0.0011,9280468,440May 22 05:00 PM
BROSHY ERANChairmanMay 21 '25Option Exercise0.0011,928034,951May 22 04:58 PM
Aspbury RobertPRESIDENT, PREDICTIVE TECHApr 01 '25Option Exercise0.0026,6260311,936Apr 03 04:44 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '25Option Exercise0.0026,6260127,669Apr 03 04:40 PM
Gallagher John EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '25Option Exercise0.0042,486051,731Apr 03 04:36 PM
Feehery William FCHIEF EXECUTIVE OFFICERApr 01 '25Option Exercise0.00111,39302,354,346Apr 03 04:32 PM
SMITH PATRICK FOfficerApr 02 '25Proposed Sale9.7320,142195,982Apr 02 10:57 AM